Author details

Full Name

Myriam Kossai

Affiliation

INSERM, Universite Clermont Auvergne

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37761816	Case Series of 11 <i>CDH1</i> Families (47 Carriers) Including Incidental Findings, Signet Ring Cell Colon Cancer and Review of the Literature.	Genes (Basel)	2023
37587334	Persistent organic pollutants promote aggressiveness in prostate cancer.	Oncogene	2023
34429252	Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC.	Urol Oncol	2022
36632297	Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials.	Rep Pract Oncol Radiother	2022
33399086	Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.	ESMO Open	2021
33516050	Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.	Eur J Cancer	2021
34487970	Refining patient selection for breast cancer immunotherapy: beyond PD-L1.	ESMO Open	2021
34659906	RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene.	Am J Cancer Res	2021
34249690	INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.	Front Oncol	2021
33933275	Benign Brenner tumour of the ovary: CT and MRI features.	Clin Radiol	2021
33948376	New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination.	Am J Cancer Res	2021
34367964	Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients.	Front Oncol	2021
32406027	Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis.	Adv Exp Med Biol	2020
33163276	Zeb1 expression by tumor or stromal cells is associated with spatial distribution patterns of CD8+ tumor-infiltrating lymphocytes: a hypothesis-generating study on 113 triple negative breast cancers.	Am J Cancer Res	2020
33327268	PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.	Medicine (Baltimore)	2020
31592503	Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.	JCO Precis Oncol	2019
29020678	Ovarian Cancer: A Heterogeneous Disease.	Pathobiology	2018
29921838	Patient derived organoids to model rare prostate cancer phenotypes.	Nat Commun	2018
29076871	Olfactory Epithelial Hamartoma: A New Subtype of Sinonasal Hamartoma.	Am J Surg Pathol	2018
29266381	Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.	Cancer	2018
28673439	[Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].	Bull Cancer	2017
29333526	Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.	JCO Precis Oncol	2017
27236348	[Glandular lesions of the uterine cervix: CaseÂ 3].	Ann Pathol	2016
26671992	The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.	Clin Cancer Res	2016
26181256	Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.	JAMA Oncol	2015
26160757	Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.	Lung Cancer	2015
26235627	The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.	Cell Rep	2015
25201530	Organoid cultures derived from patients with advanced prostate cancer.	Cell	2014
25415230	The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.	Nat Commun	2014
20097631	Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines.	Cancer Epidemiol	2010
18379416	Aberrant expression of E-cadherin in lobular carcinomas of the breast.	Am J Surg Pathol	2008

1 - 31 of 31

Lina Irshaid

Pathology Associates at Beverly Hospital

Career Start Year 2017

Number of shared co-authors 1

Nazim Benzerdjeb

Institut de Pathologie Multisite

Career Start Year 2013

Number of shared co-authors 0

Mich??le Orain

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval

Career Start Year 2013

Number of shared co-authors 2

Steven Hazell

Royal Marsden NHS Foundation Trust

Career Start Year 2011

Number of shared co-authors 0

Yingmei Wang

Tianjin Medical University General Hospital

Career Start Year 2007

Number of shared co-authors 0

Caterina Marchi??

University of Turin, Candiolo Cancer Institute, FPO-IRCCS

Career Start Year 2005

Number of shared co-authors 0

Andrew H Beck

Beth Israel Deaconess Medical Center, Harvard Medical School

Career Start Year 2004

Number of shared co-authors 3

Joerg Schwock

University of Toronto

Career Start Year 2003

Number of shared co-authors 0

Britta Weigelt

Memorial Sloan Kettering Cancer Center

Career Start Year 2002

Number of shared co-authors 9

Nicola Fusco

IEO European Institute of Oncology IRCCS

Career Start Year 2002

Number of shared co-authors 0

Sven Mahner

University Hospital

Career Start Year 2002

Number of shared co-authors 0

Blaise A Clarke

University of Toronto.

Career Start Year 2001

Number of shared co-authors 0

Steve E Kalloger

University of British Columbia

Career Start Year 2000

Number of shared co-authors 0

Jorge S Reis-Filho

Memorial Sloan-Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 21

Sang Yong Song

Center for Nanophase Materials Sciences, Oak Ridge National Laboratory

Career Start Year 1995

Number of shared co-authors 0

Paulette Mhawech-Fauceglia

University of Southern California

Career Start Year 1995

Number of shared co-authors 0

David G Huntsman

University of British Columbia

Career Start Year 1994

Number of shared co-authors 13

Bhaskar Kallakury

Georgetown University

Career Start Year 1993

Number of shared co-authors 0

Holger Moch

University Hospital Zurich

Career Start Year 1991

Number of shared co-authors 19

Paul J van Diest

University Medical Center Utrecht

Career Start Year 1989

Number of shared co-authors 3

Juan P Palazzo

Thomas Jefferson University Hospital

Career Start Year 1988

Number of shared co-authors 0

Cyril B Gilks

University of British Columbia

Career Start Year 1987

Number of shared co-authors 4

Ossama Tawfik

University of Kansas

Career Start Year 1985

Number of shared co-authors 0

Rex C Bentley

Duke School of Medicine

Career Start Year 1984

Number of shared co-authors 0

Gary L Keeney

Mayo Clinic

Career Start Year 1984

Number of shared co-authors 0

Jos?? Palacios

Universidad de Alcala

Career Start Year 1983

Number of shared co-authors 3

Hans-Peter Sinn

Pathologisches Institut, Universitatsklinikum Heidelberg

Career Start Year 1981

Number of shared co-authors 4

Bernard T??tu

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1979

Number of shared co-authors 3

Maria J Merino

National Cancer Institute, National Institutes of Health

Career Start Year 1977

Number of shared co-authors 2

Jeffrey S Ross

Foundation Medicine

Career Start Year 1974

Number of shared co-authors 14

row(s) 1 - 30 of 30

Himisha Beltran

Dana-Farber Cancer Institute

Co-authored papers 9

Juan Miguel Mosquera

Caryl and Israel Englander Institute for Precision Medicine

Co-authored papers 9

Mark A Rubin

University of Bern

Co-authored papers 8

Andrea Sboner

Institute for Computational Biomedicine

Co-authored papers 7

David M Nanus

Sandra and Edward Meyer Cancer Center

Co-authored papers 6

Olivier Elemento

Meyer Cancer Center

Co-authored papers 6

Scott T Tagawa

Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital

Co-authored papers 6

Chantal Pauli

University Hospital Zurich

Co-authored papers 5

Kenneth Eng

Caryl and Israel Englander Institute for Precision Medicine

Co-authored papers 4

Verena Sailer

Institute for Pathology, University Hospital Schleswig-Holstein

Co-authored papers 4

Brian D Robinson

Sandra and Edward Meyer Cancer Center

Co-authored papers 4

Alexandros Sigaras

Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine

Co-authored papers 4

Francesca Demichelis

University of Trento

Co-authored papers 4

Theresa Y MacDonald

Caryl and Israel Englander Institute for Precision Medicine

Co-authored papers 4

Rema Rao

Montefiore Medical Center/Albert Einstein College of Medicine

Co-authored papers 4

Joanna Cyrta

Paris Sciences Lettres University PSL, Institut CURIE